Naloxone availability in independent community pharmacies in Georgia, 2019 (original) (raw)

Naloxone Availability in Community Pharmacies, 2019

Jennifer Nguyen

2021

View PDFchevron_right

Assessing pharmacists’ readiness to dispense naloxone and counsel on responding to opioid overdoses

Carly Levy

Journal of the American Pharmacists Association, 2019

View PDFchevron_right

Naloxone availability and dispensing in Indiana pharmacies 2 years after the implementation of a statewide standing order

Beth E Meyerson

Journal of the American Pharmacists Association, 2020

View PDFchevron_right

Rural and small metro area naloxone-dispensing pharmacists' attitudes, experiences, and support for a frontline public health pharmacy role to increase naloxone uptake in New York State, 2019

Crystal Fuller Lewis

Journal of Substance Abuse Treatment, 2021

View PDFchevron_right

Pharmacists' role in opioid overdose: Kentucky pharmacists' willingness to participate in naloxone dispensing

Suzanne Troske

Journal of the American Pharmacists Association : JAPhA

View PDFchevron_right

Availability of naloxone in Canadian pharmacies:a population-based survey

Alex Cressman

CMAJ open, 2017

View PDFchevron_right

Pharmacists’ experiences with a statewide naloxone standing order program in Massachusetts: a mixed methods study

Susannah Slocum

Journal of the American Pharmacists Association, 2021

View PDFchevron_right

Orienting patients to greater opioid safety: models of community pharmacy-based naloxone

Traci Green

Harm Reduction Journal, 2015

View PDFchevron_right

The state of naloxone: Access amid a public health crisis

Jeffrey Fudin

Medicine Access @ Point of Care

View PDFchevron_right

How prepared are pharmacists to provide over-the-counter naloxone? The role of previous education and new training opportunities

Meng-Wong Taing

Research in Social and Administrative Pharmacy

View PDFchevron_right

Pharmacy-based statewide naloxone distribution: A novel "top-down, bottom-up" approach

Claire Logan

Journal of the American Pharmacists Association : JAPhA

View PDFchevron_right

Attitudes and perceptions of naloxone dispensing among a sample of Massachusetts community pharmacy technicians

Traci Green

Journal of the American Pharmacists Association

View PDFchevron_right

If We Build It, Will They Come? Perspectives on Pharmacy-Based Naloxone Among Family and Friends of People who use Opioids: A Mixed Methods Study

Susannah Slocum

2021

View PDFchevron_right

Socio-ecological and pharmacy-level factors associated with naloxone stocking at standing-order naloxone pharmacies in New York City

Dr. Dawn A. Goddard-Eckrich

Drug and Alcohol Dependence, 2021

View PDFchevron_right

Acceptability of Naloxone Dispensing Among Pharmacists

Michelle Geier

Journal of Pharmacy Practice

View PDFchevron_right

PHArmacists’ perspective oN the Take hOme naloxone prograM (The PHANTOM Study)

duane bates

Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, 2017

View PDFchevron_right

Investigating Community Pharmacy Take Home Naloxone Dispensing during COVID-19: The Impact of One Public Health Crisis on Another

Ashley Polanco Cid

Pharmacy, 2021

View PDFchevron_right

Association of Naloxone Coprescription Laws With Naloxone Prescription Dispensing in the United States

Zhengyan Huang

JAMA Network Open, 2019

View PDFchevron_right

Physicians’ Knowledge of and Willingness to Prescribe Naloxone to Reverse Accidental Opiate Overdose: Challenges and Opportunities

Leo Beletsky

Journal of Urban Health, 2007

View PDFchevron_right

How do contextual factors influence naloxone distribution from syringe service programs in the USA: a cross-sectional study

Savannah O'Neill

Harm Reduction Journal, 2023

View PDFchevron_right

Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015

Thomas Stopka

Journal of the American Pharmacists Association : JAPhA

View PDFchevron_right

The Emergency Department as an Opportunity for Naloxone Distribution

Nicole Schramm-sapyta

Western Journal of Emergency Medicine

View PDFchevron_right

Facilitators and Barriers to Naloxone Kit Use Among Opioid-Dependent Patients Seeking Treatment at Medication Assisted Therapy Clinics in North Carolina, USA ABSTRACT Facilitators and Barriers to Naloxone Kit Use Among Opioid-Dependent Patients Seeking Treatment at Medication Assisted Therapy Cli...

Prasana Khatiwoda

2016

View PDFchevron_right

Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders

Paxton Bach

Addiction Science & Clinical Practice

View PDFchevron_right

Preliminary Evidence of Health Care Provider Support for Naloxone Prescription as Overdose Fatality Prevention Strategy in New York City

David Vlahov, Phillip Coffin

Journal of Urban Health: Bulletin of the New York Academy of Medicine, 2003

View PDFchevron_right

Awareness of state legislation on naloxone accessibility associated with willingness to prescribe naloxone

Olihe Okoro

Substance Abuse, 2017

View PDFchevron_right

Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Texas, USA

Joshua Perez

Addiction, 2020

View PDFchevron_right

A nationwide pharmacy chain responds to the opioid epidemic

Chester Robson

Journal of the American Pharmacists Association, 2017

View PDFchevron_right

Predicting pharmacy naloxone stocking and dispensing following a statewide standing order, Indiana 2016

Ruth Gassman

Drug and Alcohol Dependence, 2018

View PDFchevron_right